- Humana (Austin, TX)
- …compliance standards for our Pharmacy and Therapeutics Committee. The Senior Pharmacy Clinical Advisor analyzes and measures the effectiveness of existing ... Clinical Pharmacists, and manage external relationships. The Senior Pharmacy Clinical Advisor work assignments involve moderately complex to complex issues… more
- Merck (Austin, TX)
- …translational PK/PD approaches, population pharmacokinetic models, exposure-response models, clinical trial design simulation, disease progression models, ... team in the role of Director. QP2-IO team is part of the Global Clinical Development organization and has oversight over drug development aspects related to … more
- Merck (Austin, TX)
- …Design Control and Device Risk Management documentation for regulatory filings, clinical supply, development, design transfer qualification and post marketing ... & Development Division device functions and other personnel to ensure end-to-end Design Control principles are implemented effectively. + Participate in design … more
- Merck (Austin, TX)
- …in the role of Senior Specialist. QP2-IO team is part of the Global Clinical Development organization and has oversight over drug development aspects related to ... clinical pharmacology and pharmacometrics of oncology drugs from post-Preclinical...or other similar programing language. + Skills in experimental design , mathematical problem solving, critical data analysis/interpretation, and statistics… more
- Omnicell, Inc. (Austin, TX)
- …Omnicell has been committed to **transforming pharmacy care** through **outcomes-centric innovation ** designed to optimize clinical and business outcomes across ... Benefits: Your benefits start on your first day. We design our health, insurance, retirement, educational, and well-being programs...to a community's well-being and act as a trusted advisor to your patients while being a part of… more
- Merck (Austin, TX)
- …novel quantitative approaches that seek to improve cycle time, cost/size, number of trials, clinical trial design and Go/No Go decisions + Framing critical drug ... PK/PD models, exposure response (ER) models, model-based meta-analysis (MBMA), clinical trial simulations (CTS) and disease progression modeling into programs… more
- Merck (Austin, TX)
- …novel quantitative approaches that seek to improve cycle time, cost/size, number of trials, clinical trial design and Go/No Go decisions . Serve as a subject ... pharmacokinetics (PK) and pharmacodynamics (PD) analysis, model-based meta-analysis (MBMA), clinical trial simulations (CTS), disease progression modeling and Artificial… more